Acute Respiratory Distress Syndrome Clinical Trial
Official title:
Factors Associated With the Use of Lung Protective Ventilation Strategy (LPV) in ALI/ARDS Patients in ICU
In 1967, Ashbaugh et al first described 12 patients with a syndrome characterized by the
acute onset dyspnea, severe hypoxemia, diffuse lung infiltrates on the chest radiography and
decreased lung compliance. Moreover, in 1988, Murray et al proposed a lung injury scoring
system based on the level of positive end-expiratory pressure (PEEP), PaO2-to-FiO2 ratio,
static lung compliance, degree of infiltrates on the chest radiograph, and clinical cause. A
score of 2.5 or greater was considered to be consistent with a diagnosis of ARDS. The
current definition of ARDS was proposed by Bernard et al and the American-European Consensus
Conference in 1994. The criteria of ARDS included: 1) acute onset; 2) a PaO2/FIO2 ratio, or
hypoxia score, of < 200, regardless of positive endexpiratory pressure; 3) bilateral
infiltrates on chest radiograph; and 4) a pulmonary artery occlusion pressure of <18 mm Hg
or the absence of clinical evidence of left atrial hypertension.
However, despite advances in ventilator management, the mortality rate of acute lung injury
and the acute respiratory distress syndrome remains very high (approximately 40 to 50
percent). In 2000, ARDS Network trial compared the effects of 6 versus 12 mL/kg of tidal
volume per predicted body weight (PBW) among 861 patients and noted an overall 22% reduction
in mortality rate, more ventilator-free days, and more organ-failure-free days in the
low-tidal-volume group. Therefore, the current approach to mechanical ventilation of a
patient with ARDS emphasizes the use of lower tidal volumes with lower pressures to avoid
causing lung overdistension and ventilator associated lung injury.
Nevertheless, one year after publication of the ARDSnet trial, Rubenfeld et al noted that
lung-protective ventilation strategies were applied in less than 5% of patients with ARDS or
ALI at a single ARDSnet center. Rubenfeld et al found that common barriers to the initiation
of low tidal volume ventilation include unwillingness to relinquish control of the
ventilator, failure to recognize patients as having ALI/ARDS, and perceived
contraindications to low tidal volume ventilation. Significant barriers to the continuation
of low tidal volume ventilation include concerns regarding patient discomfort and tachypnea
or hypercapnia and acidosis.
In addition, Kalhan et al also evaluated factors associated with the choice of tidal volume
and he reported that underuse of LPV may be related to clinicians' under-recognition of less
severe cases of ALI, and their reserving of low-tidal volume ventilation for more severe
cases, or both. However, the factors such as comorbidity and pathophysiological change
associated with underuse of lung protective ventilation strategy are not clear. The
investigators perform a prospective single-center study to investigate the factors
associated with the use of lung protective ventilation strategy (LPV) in ALI/ARDS patients
in ICU.
In 1967, Ashbaugh et al first described 12 patients with a syndrome characterized by the
acute onset dyspnea, severe hypoxemia, diffuse lung infiltrates on the chest radiography and
decreased lung compliance. The syndrome, initially called acute respiratory distress in
adult and is now named as the acute respiratory distress syndrome (ARDS). Moreover, in 1988,
Murray et al proposed a lung injury scoring system based on the level of positive
end-expiratory pressure (PEEP),PaO2-to-FiO2 ratio, static lung compliance, degree of
infiltrates on the chest radiograph, and clinical cause. A score of 2.5 or greater was
considered to be consistent with a diagnosis of ARDS. The current definition of ARDS was
proposed by Bernard et al and the American-European Consensus Conference in 1994. The
criteria of ARDS included: 1) acute onset; 2) a PaO2/FIO2 ratio, or hypoxia score, of <200,
regardless of positive endexpiratory pressure; 3) bilateral infiltrates on chest radiograph;
and 4) a pulmonary artery occlusion pressure of <18 mm Hg or the absence of clinical
evidence of left atrial hypertension.
However, despite advances in ventilator management, the mortality rate of acute lung injury
and the acute respiratory distress syndrome remains very high (approximately 40 to 50
percent). In 2000, ARDS Network trial compared the effects of 6 versus 12 mL/kg of tidal
volume per predicted body weight(PBW) among 861 patients and noted an overall 22% reduction
in mortality rate, more ventilator-free days, and more organ-failure-free days in the
low-tidal-volume group. Therefore, the current approach to mechanical ventilation of a
patient with ARDS emphasizes the use of lower tidal volumes with lower pressures to avoid
causing lung overdistension and ventilator associated lung injury.
Nevertheless, one year after publication of the ARDSnet trial, Rubenfeld et al noted that
lung-protective ventilation strategies were applied in less than 5% of patients with ARDS or
ALI at a single ARDSnet center. Rubenfeld et al found that common barriers to the initiation
of low tidal volume ventilation include unwillingness to relinquish control of the
ventilator, failure to recognize patients as having ALI/ARDS, and perceived
contraindications to low tidal volume ventilation. Significant barriers to the continuation
of low tidal volume ventilation include concerns regarding patient discomfort and tachypnea
or hypercapnia and acidosis.
In addition, Kalhan et al also evaluated factors associated with the choice of tidal volume
and he reported that underuse of LPV may be related to clinicians' under-recognition of less
severe cases of ALI, and their reserving of low-tidal volume ventilation for more severe
cases, or both. However, the factors such as comorbidity and pathophysiological change
associated with underuse of lung protective ventilation strategy are not clear. We perform a
prospective single-center study to investigate the factors associated with the use of lung
protective ventilation strategy (LPV) in ALI/ARDS patients in ICU
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
| Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
| Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
| Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
| Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
| Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
| Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
| Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
| Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
| Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
| Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
| Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
| Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
| Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
| Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
| Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
| Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A | |
| Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A |